The role of estrogen, testosterone, and parathyroid hormones in combination with conventional and sustained antioxidant treatment on LNCAP cells

Biomedical Sciences Instrumentation

Volumn 45, Issue , 2009, Pages 268-273

  Richards, La'Toya Ross ^a   Wilson, Felisa ^a   Benghuzzi, Hamed ^a   Tucci, Michelle ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Estrogen (EST); Parathyroid hormone (PTH); Prostate cancer; Testosterone (TST)

Indexed keywords

ANTIOXIDANT TREATMENT; CHAIN REACTION; ESTROGEN (EST); GALLATE; LNCAP CELLS; PARATHYROID HORMONE (PTH); PARATHYROID HORMONES; PEROXIDATION; PROSTATE CANCER; PROSTATE CANCERS; PROSTATE GLANDS; PUBLIC HEALTH ISSUES; TANNIC ACID; TESTOSTERONE (TST); THYMOQUINONE;

CALCIUM; CALCIUM PHOSPHATE; ENDOCRINOLOGY; GROWTH KINETICS; HORMONES;

OPTICAL TOMOGRAPHY;

EPIGALLOCATECHIN GALLATE; ESTROGEN; PARATHYROID HORMONE; TANNIN; TESTOSTERONE; THYMOQUINONE;

CELL COUNT; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL STRUCTURE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROSTATE CANCER;

EID: 65749120709     PISSN: 00678856     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Arnold, J.T.; Le, H, McFann KK, Blackman MR. (2005) Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. American Journal of Physiology and Endocrinology Metabolism 3:E573-584.
2. Beger, C, Ramadani, M., Meyer S., Leder G., Krüger, M., Welte, K., Gansauge, F.,Beger H. (2004) Down-Regulation of BRCA1 in Chronic Pancreatitis and Sporadic Pancreatic Adenocarcinoma. Clinical Cancer Research 10: 3780-3787.
3. Bhasin, S. (2003) Regulation of body composition by androgens. Journal of Endocrinology Invest. 9:814-822.
4. Chang, H., Miyamoto, H., Marwah, P., Henry, L., Yeh, S., Huang, K. Chang C. (1999) Suppression of Δ5-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells. Proc Natl Acad Sci 20: 11173-11177.
5. Green PS, Gordon K, Simpkins JW. (1997) Phenolic A ring requirement for the neuroprotective effects of steroids. Journal of Steroid Biochem Mol Biol. 63:229-235.
6. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. (2001) Cancer Statistics. CA Cancer J Clin.1:15-36.
7. Halliwell B. (1998) Can oxidative DNA damage be used as a biomarker of cancer risk in humans? Problems, resolutions and preliminary results from nutritional supplementation studies. Free Radic Res. 6:469-486.
8. Harman, SM. (2005) Testosterone in older men after the Institute of Medicine Report: Where do we go from here? Climacteric 2: 124-135.
9. Horoszewicz, J.S., Leong, S. S.; Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A., Murphy, G. P.(1983) LNCaP model of human prostatic carcinoma. Cancer Research 43: 1809-1818.
10. Sugioka K, Shimosegawa Y, Nakano M. (1987) Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett. 1:37-39.
11. Tanaka H, Tachibana T, Oda R, Dasgupta PK. (2004) Determination of acid dissociation constants based on continuous titration by feedback-based flow ratiometry.